Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Ablynx
Pharma
Sanofi taps Harvard spinout for oral nanobody delivery work
The partners will use i2O’s platform for protecting peptides and proteins to end the need for nanobodies to be injected.
Nick Paul Taylor
Feb 16, 2021 7:35pm
Cablivi is Sanofi’s first approval from Ablynx buyout
Feb 6, 2019 12:23pm
Sanofi’s first Ablynx drug Cablivi wins EU approval
Sep 4, 2018 11:08am
Sanofi’s first product from the Ablynx deal wins CHMP backing
Jun 29, 2018 10:16am
Sanofi recruits new CFO to replace outgoing Contamine
Jun 19, 2018 10:23am
Sanofi scouts new CFO to replace retiring Jérôme Contamine
Apr 18, 2018 12:08pm